Graf Akcie OTLK (Outlook Therapeutics Inc). Diskuze k akciím OTLK. Aktuální informace OTLK.

Základní informace o společnosti Outlook Therapeutics Inc (Akcie OTLK)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 366.31M
Hodnota podniku (EV) 385.75M
Tržby 0.00
EBITDA -26.41
Zisk -49.68
Růst v tržbách Q/Q N/A %
Růst v tržbách Y/Y N/A %
P/E (Cena vůči ziskům) N/A
Forward P/E -0.05
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales N/A
P/FCF N/A
Price/Book 131.45
Účetní hodnota na akcii 0.02
Hotovost na akcii 0.07
FCF vůči ceně -15.43 %
Počet zaměstnanců 8
Tržba na zaměstnance N/A
Profit margin -840.70 %
Operating margin N/A %
Gross margin 100.00 %
EBIT margin N/A %
EBITDA margin N/A %
EPS - Zisk na akcii N/A
EPS - Kvartální růst 133.33 %
EPS - Očekávaný růst příští rok -46.15 %
Return on assets -180.26 %
Return on equity -771.69 %
ROIC -233.31 %
ROCE -369.95 %
Dluhy/Equity 5.98
Čistý dluh/EBITDA 1.49
Current ratio 1.62
Quick Ratio 1.62
Volatilita 5.15
Beta 2.29
RSI 38.87
Cílová cena analytiků 5
Známka akcie (dle analytiků) 1.00
Insider ownership 47.89 %
Institutional ownership 12.90 %
Počet akcií 175.341M
Procento shortovaných akcií 3.20 %
Short ratio 5.15 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2016
Země United States

Finanční výsledky akcie OTLK

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue-$8.146$3.088$3.812$2.98$5.219$9.051$9.051
Cost Of Goods Sold--------
Gross Profit-$8.146$3.088$3.812$2.98$5.219$9.051$9.051
Research And Development Expenses$26.342$23.805$18.504$23.81$32.763$38.876$14.125-
SG&A Expenses$9.971$9.37$14.228$15.882$21.564$12.906$7.318$7.318
Other Operating Income Or Expenses$-0.528$-11.27------
Operating Expenses$36.841$44.445$32.732$39.692$54.327$51.782$21.443$7.318
Operating Income$-36.841$-36.299$-29.644$-35.88$-51.347$-46.563$-12.392$1.732
Total Non-Operating Income/Expense$-1.671$-1.636$-4.096$-2.467$-1.852$-2.297$-0.901$-0.901
Pre-Tax Income$-38.512$-37.935$-33.74$-38.348$-53.199$-48.86$-13.294$-13.294
Income Taxes$-3.272$-3.411$-3.648$0.502$0.103$-0.19$0.439$0.439
Income After Taxes$-35.24$-34.524$-30.092$-38.849$-53.302$-48.67$-13.733$-13.733
Other Income--------
Income From Continuous Operations$-35.24$-34.524$-30.092$-38.849$-53.302$-48.67$-13.733$-13.733
Income From Discontinued Operations--------
Net Income$-48.874$-36.04$-48.019$-40.026$-63.139$-52.998$-20.658$-13.733
EBITDA$-36.287$-32.937$-26.59$-33.188$-48.953$-44.738$-11.514$1.732
EBIT$-36.841$-36.299$-29.644$-35.88$-51.347$-46.563$-12.392$1.732
Basic Shares Outstanding731853211-
Shares Outstanding731853211-
Basic EPS$-0.67$-1.98$-9.74$-13.36$-29.36$-43.44$-19.44-
EPS - Earnings Per Share$-0.67$-1.98$-9.74$-14.40$-29.36$-43.44$-19.44-
# 2020 2019 2018 2017 2016 2015
Current Ratio1.12930.66540.10310.13590.27790.4094
Long-term Debt / Capital0.2509-0.4645-0.2058-0.7745-0.9756-0.1594
Debt/Equity Ratio1.6415-1.3877-1.0538-0.5994-1.6878-0.4915
Gross Margin-100100100100100
Operating Margin--445.5992-960.1208-941.3639-1723.305-892.1348
EBIT Margin--445.5992-960.1208-941.3639-1723.305-892.1348
EBITDA Margin--404.3296-861.1964-870.7333-1642.948-857.1757
Pre-Tax Profit Margin--465.679-1092.778-1006.098-1785.455-936.1515
Net Profit Margin--442.415-1555.236-1050.129-2119.059-1015.444
Asset Turnover-0.47540.13860.18380.11730.1491
Inventory Turnover Ratio------
Receiveable Turnover-----1.2137
Days Sales In Receivables-----300.7249
ROE - Return On Equity-1246.858214.0431117.8002115.44731030.40988.6942
Return On Tangible Equity-1246.846320.5564144.5998126.43521030.407108.9227
ROA - Return On Assets-178.5856-201.4812-135.0415-187.3704-209.8013-139.0225
ROI - Return On Investment-933.9981469.4607174.3575224.35852035.698126.2814
Book Value Per Share0.0222-0.3764-2.3054-9.8585-1.8148-37.883
Operating Cash Flow Per Share1.33694.924-1.539715.97951.3965-15.9356
Free Cash Flow Per Share1.36095.4639-2.006416.39278.1072-20.9317